139 related articles for article (PubMed ID: 21514265)
61. On an Equal Distribution of Excitement, and of the Circulating Fluids.
Kinglake
Lond Med Phys J; 1822 Nov; 48(285):392-397. PubMed ID: 30494638
[No Abstract] [Full Text] [Related]
62. The Appropriate Amount of Fluids.
Zijlstra GJ
Chest; 2024 Feb; 165(2):e58-e59. PubMed ID: 38336446
[No Abstract] [Full Text] [Related]
63. The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities.
Zaporozhchenko IA; Ponomaryova AA; Rykova EY; Laktionov PP
Expert Rev Mol Diagn; 2018 Feb; 18(2):133-145. PubMed ID: 29307231
[TBL] [Abstract][Full Text] [Related]
64. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
65. An optimized procedure for exosome isolation and analysis using serum samples: Application to cancer biomarker discovery.
Li M; Rai AJ; DeCastro GJ; Zeringer E; Barta T; Magdaleno S; Setterquist R; Vlassov AV
Methods; 2015 Oct; 87():26-30. PubMed ID: 25814440
[TBL] [Abstract][Full Text] [Related]
66. Maternal plasma RNA sequencing for genome-wide transcriptomic profiling and identification of pregnancy-associated transcripts.
Tsui NB; Jiang P; Wong YF; Leung TY; Chan KC; Chiu RW; Sun H; Lo YM
Clin Chem; 2014 Jul; 60(7):954-62. PubMed ID: 24740362
[TBL] [Abstract][Full Text] [Related]
67. The complete exosome workflow solution: from isolation to characterization of RNA cargo.
Schageman J; Zeringer E; Li M; Barta T; Lea K; Gu J; Magdaleno S; Setterquist R; Vlassov AV
Biomed Res Int; 2013; 2013():253957. PubMed ID: 24205503
[TBL] [Abstract][Full Text] [Related]
68. A Comprehensive Review on Circulating cfRNA in Plasma: Implications for Disease Diagnosis and Beyond.
Zhong P; Bai L; Hong M; Ouyang J; Wang R; Zhang X; Chen P
Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786343
[TBL] [Abstract][Full Text] [Related]
69. Circulating cell-free nucleic acids of plasma in human aging, healthy aging and longevity: current state of knowledge.
Tessier NP; Hardy LM; Deleuze JF; How-Kit A
Front Genet; 2023; 14():1321280. PubMed ID: 38090154
[TBL] [Abstract][Full Text] [Related]
70. Cell-free RNA signatures predict Alzheimer's disease.
Cisterna-García A; Beric A; Ali M; Pardo JA; Chen HH; Fernandez MV; Norton J; Gentsch J; Bergmann K; Budde J; Perlmutter JS; Morris JC; Cruchaga C; Botia JA; Ibanez L
iScience; 2023 Dec; 26(12):108534. PubMed ID: 38089583
[TBL] [Abstract][Full Text] [Related]
71. A Novel Application of Spinning Disk Technology to Collect Plasma from Whole Blood Prior to Quantifying Plasma RNA.
Rapier-Sharman N; Hutchinson ML; Moreno CM; Quaye A; Poole BD; Weber KS; Pitt WG; Pickett BE
MicroPubl Biol; 2023; 2023():. PubMed ID: 38021167
[TBL] [Abstract][Full Text] [Related]
72. Liquid Biopsy in Lung Cancer: Biomarkers for the Management of Recurrence and Metastasis.
Souza VGP; Forder A; Brockley LJ; Pewarchuk ME; Telkar N; de Araújo RP; Trejo J; Benard K; Seneda AL; Minutentag IW; Erkan M; Stewart GL; Hasimoto EN; Garnis C; Lam WL; Martinez VD; Reis PP
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240238
[TBL] [Abstract][Full Text] [Related]
73. Sequence-Based Platforms for Discovering Biomarkers in Liquid Biopsy of Non-Small-Cell Lung Cancer.
Brockley LJ; Souza VGP; Forder A; Pewarchuk ME; Erkan M; Telkar N; Benard K; Trejo J; Stewart MD; Stewart GL; Reis PP; Lam WL; Martinez VD
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190212
[TBL] [Abstract][Full Text] [Related]
74. Plasma cell-free RNA characteristics in COVID-19 patients.
Wang Y; Li J; Zhang L; Sun HX; Zhang Z; Xu J; Xu Y; Lin Y; Zhu A; Luo Y; Zhou H; Wu Y; Lin S; Sun Y; Xiao F; Chen R; Wen L; Chen W; Li F; Ou R; Zhang Y; Kuo T; Li Y; Li L; Sun J; Sun K; Zhuang Z; Lu H; Chen Z; Mai G; Zhuo J; Qian P; Chen J; Yang H; Wang J; Xu X; Zhong N; Zhao J; Li J; Zhao J; Jin X
Genome Res; 2022 Feb; 32(2):228-241. PubMed ID: 35064006
[TBL] [Abstract][Full Text] [Related]
75. Do Extracellular RNAs Provide Insight into Uveal Melanoma Biology?
Barbagallo C; Platania CBM; Drago F; Barbagallo D; Di Pietro C; Purrello M; Bucolo C; Ragusa M
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885029
[TBL] [Abstract][Full Text] [Related]
76. NcRNAs in Vascular and Valvular Intercellular Communication.
Bartsch B; Goody PR; Hosen MR; Nehl D; Mohammadi N; Zietzer A; Düsing P; Pfeifer A; Nickenig G; Jansen F
Front Mol Biosci; 2021; 8():749681. PubMed ID: 34805273
[TBL] [Abstract][Full Text] [Related]
77. Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy.
Kachris S; Papadaki C; Rounis K; Tsitoura E; Kokkinaki C; Nikolaou C; Sourvinos G; Mavroudis D
Cancer Manag Res; 2021; 13():8257-8271. PubMed ID: 34754245
[TBL] [Abstract][Full Text] [Related]
78. Muscle Regeneration and RNA: New Perspectives for Ancient Molecules.
Buonaiuto G; Desideri F; Taliani V; Ballarino M
Cells; 2021 Sep; 10(10):. PubMed ID: 34685492
[TBL] [Abstract][Full Text] [Related]
79. Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors.
Xu L; Cai Y; Chen X; Zhu Y; Cai J
BMC Cancer; 2021 Sep; 21(1):989. PubMed ID: 34479528
[TBL] [Abstract][Full Text] [Related]
80. Non-Coding RNAs as Blood-Based Biomarkers in Cardiovascular Disease.
Videira RF; da Costa Martins PA; Falcão-Pires I
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
